Main Category: Obesity / Weight Loss / Fitness Also Included In: Diabetes ; Sexual Health / STDs Article Date: 19 Aug 2011 – 2:00 PDT A recent investigation has confirmed sexual desire and performance can be significantly improved in obese diabetic men if they lose weight on a high protein or low calorie diet.
The campers and camp counselors gather around in a circle. It’s a sweet morning at Camp Patterson on Lake Washington, and it’s time for a game.
Initial sitagliptin/metformin combination therapy provides superior glycemic control compared to metformin monotherapy
A treatment strategy involving initial combination therapy with sitagliptin/metformin as a fixe… [ August 19, 2011 ]
A recent investigation has confirmed sexual desire and performance can be significantly improved in obese diabetic men if they lose weight on a high protein or low calorie diet…
Save $12 off $100 Order – USE CODE DMART12100.Shop diabetic supplies online visit http://tinyurl.com/4pvffex and use coupon at checkout #diabetes #cheaptweets #coupon
Sandoz Inc., a unit of the Swiss drug company Novartis AG , filed a federal lawsuit in Detroit seeking the court’s finding that its proposed generic version of a Novo Nordisk A/S diabetes drug is non-infringing. Sandoz plans to market a lower cost version of the Novo Nordisk diabetes drug Prandin , according to a complaint filed yesterday.
Some of Cleveland’s most talented female vocalists are teaming up in “Divas for Diabetes,” a musical fundraiser on Aug.
Blood glucose testing by point-of-care meters has become increasingly prevalent, and is an essential tool in diabetes management.
Prevalence and Characteristics of Painful Diabetic Neuropathy in a Large Community-Based Diabetes Population in the U.K.
To assess, in the general diabetic population, 1) the prevalence of painful neuropathic symptoms; 2) the relationship between symptoms and clinical severity of neuropathy; and 3) the role of diabetes type, sex, and ethnicity in painful neuropathy.
RESEARCH DESIGN AND METHODS
Observational study of a large cohort of diabetic patients receiving community-based healthcare in northwest England (n = 15,692). Painful diabetic neuropathy (PDN) was assessed using neuropathy symptom score (NSS) and neuropathy disability score (NDS).
Prevalence of painful symptoms (NSS ≥5) and PDN (NSS ≥5 and NDS ≥3) was 34 and 21%, respectively. Painful symptoms occurred in 26% of patients without neuropathy (NDS ≤2) and 60% of patients with severe neuropathy (NDS >8). Adjusted risk of painful neuropathic symptoms in type 2 diabetes was double that of type 1 diabetes (odds ratio [OR] = 2.1 [95% CI 1.7–2.4], P < 0.001) and not affected by severity of neuropathy, insulin use, foot deformities, smoking, or alcohol. Women had 50% increased adjusted risk of painful symptoms compared with men (OR = 1.5 [1.4–1.6], P < 0.0001). Despite less neuropathy in South Asians (14%) than Europeans (22%) and African Caribbeans (21%) (P < 0.0001), painful symptoms were greater in South Asians (38 vs. 34 vs. 32%, P < 0.0001). South Asians without neuropathy maintained a 50% increased risk of painful neuropathy symptoms compared with other ethnic groups (P < 0.0001).
One-third of all community-based diabetic patients have painful neuropathy symptoms, regardless of their neuropathic deficit. PDN was more prevalent in patients with type 2 diabetes, women, and people of South Asian origin. This highlights a significant morbidity due to painful neuropathy and identifies key groups who warrant screening for PDN.